Renal Cancer Treatment: What's New?

Dear Dr. Renukaprasad A R, Cytoreductive nephrectomy (CRN) poses major therapeutic challenges concerning patient factors, the timing of surgery, and its combination with other therapies. Though some subgroups may benefit, with the development of targeted therapies, CRN is no longer the standard of care for metastatic renal cell carcinoma. Therefore, better clinical, genetic, or molecular risk stratification is required to determine the timing of surgery and the most suitable candidates. In this era of immunotherapy, the role of CRN needs to evolve with the potential to offer surgical interventions with minimal delay in systemic treatment. To learn more about the therapeutic approaches to kidney cancer, join Dr. Saurabh Patil for an exclusive session on "Role of Cytoreductive Nephrectomy in Advanced Renal Cancers" TODAY at 3:00 PM IST. Click to Join   India's Largest Online Community of Verified Doctors Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*